Ascites, the accumulation of fluid in the abdominal cavity, develops through a cascade of events that begins with increased pressure in the portal vein and spirals outward to involve the arteries, kidneys, hormonal systems, and lymphatic drainage. In liver cirrhosis, which accounts for the vast majority of cases, no single broken mechanism explains the fluid buildup. Instead, several physiological failures layer on top of one another, each worsening the others, until the body is trapped in a cycle of salt retention, water retention, and fluid leakage it cannot reverse on its own.
Portal Hypertension Sets the Stage
The process starts inside the liver itself. In cirrhosis, scar tissue distorts the normal architecture of the organ and physically narrows the tiny channels (sinusoids) through which blood flows. This increases resistance to blood entering the liver from the portal vein, which collects blood from the intestines, spleen, and stomach. The resulting backup of pressure is called portal hypertension, and it is the single most important prerequisite for ascites to form.1PubMed Central. Pathophysiology of portal hypertension
But high portal pressure alone is not enough. Researchers have known for decades that some patients with elevated portal pressure never develop ascites, while others with modest elevations do. The missing pieces involve what happens to the rest of the circulation once portal pressure rises.
Arterial Vasodilation and the Underfilling Problem
As portal pressure climbs, the blood vessels in the gut and surrounding organs (the splanchnic circulation) begin to widen. This dilation is driven largely by nitric oxide and other vasodilating substances that accumulate because the damaged liver can no longer clear them efficiently. The widened splanchnic arteries pool blood in the abdominal organs, effectively pulling it away from the central arterial circulation.
The body registers this shift as a drop in “effective” blood volume, even though total blood volume is actually higher than normal. The heart is pumping more blood per minute, and blood pressure tends to run low. This paradox sits at the center of what is known as the peripheral arterial vasodilation hypothesis, the dominant framework for understanding ascites since the early 1990s.2PubMed. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis According to this model, the relative emptying of the arterial tree triggers a hormonal alarm response aimed at restoring circulatory volume.3PubMed. Mechanism of sodium retention and ascites formation in cirrhosis
An older model, sometimes called the “backward” theory, proposed that ascites was simply the result of high hydrostatic pressure in the liver’s sinusoids pushing fluid out, combined with low albumin levels reducing the blood’s ability to hold onto water. This idea made intuitive sense but could not explain why patients with cirrhosis have such high cardiac output and low vascular resistance. The forward theory, centered on splanchnic vasodilation, accounts for those observations much more convincingly.4Annals of Hepatology. Pathophysiology, diagnosis and treatment of ascites in cirrhosis In practice, both forward pressure changes and backward pressure changes contribute, but the arterial vasodilation framework is now the more widely accepted explanation.
How the Kidneys Get Pulled In
Once the body senses arterial underfilling, it activates three major compensatory systems almost simultaneously. The renin-angiotensin-aldosterone system ramps up, telling the kidneys to hold on to sodium. The sympathetic nervous system fires more aggressively, constricting blood vessels in the kidneys and other organs. And vasopressin (sometimes called antidiuretic hormone) is released independently of normal osmotic triggers, telling the kidneys to retain water.5PubMed. Mechanism of sodium retention and ascites formation in cirrhosis
These systems are designed to be temporary fixes during emergencies like dehydration or hemorrhage. In cirrhosis, they stay permanently switched on because the underlying arterial underfilling never resolves. The kidneys dutifully retain sodium, which drags water along with it, expanding plasma volume further. But because the splanchnic vessels keep dilating, the extra volume pools in the abdomen rather than restoring central arterial pressure. The hormonal alarm never shuts off.
An earlier competing view, the “overflow” hypothesis, proposed that a signal originating in the liver’s sinusoids directly stimulates the kidneys to retain sodium before any arterial underfilling occurs. According to this model, intrahepatic hypertension activates a hepatic baroreceptor reflex that enhances renal sodium absorption, expanding plasma volume. The extra fluid then gets sequestered in the peritoneal cavity as Starling forces across the liver’s surface become deranged.6PubMed. Cirrhotic ascites. Pathophysiology, diagnosis, and management While this mechanism likely contributes in earlier stages of cirrhosis, the vasodilation model better explains what happens as the disease progresses and arterial pressures fall.
The Role of Vasopressin and Dilutional Hyponatremia
Of the three hormonal arms activated in ascites, vasopressin deserves particular attention because it drives one of the most dangerous complications: hyponatremia, or dangerously low blood sodium concentration. The problem is counterintuitive. The body is retaining both sodium and water, so you might expect sodium levels to stay normal. But vasopressin causes the kidneys to retain water out of proportion to sodium, diluting the blood.
Vasopressin works by binding to receptors in the kidney’s collecting ducts, which respond by inserting water channels (called aquaporin-2) into their cell membranes. More channels mean more water reabsorption. In cirrhosis, vasopressin levels are chronically elevated and the liver’s reduced ability to break down the hormone keeps it circulating longer than it should. The kidneys end up retaining so much extra water that sodium in the blood becomes progressively diluted.7Gastroenterology Report. Ascites, refractory ascites and hyponatremia in cirrhosis Low sodium in a patient with cirrhosis is a marker of severe disease and is associated with worse outcomes.
When the Lymphatic System Gets Overwhelmed
Even with all the hormonal and circulatory disruption described so far, fluid would not accumulate in the abdominal cavity if it had somewhere else to go. Under normal conditions, some fluid does leak from the liver’s surface and intestinal capillaries into the peritoneal space, but it gets picked up by lymphatic vessels and returned to the bloodstream via the thoracic duct, a large lymphatic channel that empties into a vein near the neck.
In cirrhosis, the volume of lymph produced by the liver and splanchnic organs increases dramatically. As long as the lymphatic system can keep up, ascites does not form. Ascites appears when production overwhelms drainage.8PubMed Central. Clinical implications of thoracic duct dilatation in patients with chronic liver disease In advanced disease, the thoracic duct itself visibly dilates as it struggles to handle the flow, and in patients with refractory ascites, this dilation can be extreme. The lymphatic overflow is the final bottleneck that determines whether the cascade of portal hypertension, vasodilation, and salt retention actually produces clinically apparent fluid in the belly.
Interestingly, research in animals with right heart failure has found that fluid overload correlates more closely with lymphatic dysfunction than with the severity of the heart’s hemodynamic problems. Changes like regurgitant lymphatic flow and increased thoracic duct diameter predicted ascites better than cardiac pressures did.9PubMed Central. Ascites in Animals With Right Heart Failure: Correlation With Lymphatic Dysfunction This suggests the lymphatic system may be more than a passive overflow valve; its failure could be an active contributor to ascites in both liver and cardiac disease.
The Serum-Ascites Albumin Gradient
Understanding the pathophysiology of ascites has practical diagnostic consequences. When a clinician taps the abdominal fluid, one of the first tests ordered is the serum-ascites albumin gradient, commonly abbreviated SAAG. This is simply the difference between the albumin concentration in the blood and the albumin concentration in the ascitic fluid. A high gradient (1.1 g/dL or more) indicates that portal hypertension is the driving force behind the fluid, while a low gradient points toward other causes like cancer, tuberculosis, or pancreatic disease.10PubMed. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites
The gradient works because portal hypertension creates a specific pattern of oncotic (protein-related) pressure imbalance between the blood and the peritoneal fluid. The higher the portal pressure, the wider the gap between blood albumin and ascitic albumin, because the fluid being pushed out of the circulation is relatively protein-poor. Conditions that cause ascites through inflammation or tumor deposits, on the other hand, produce protein-rich fluid and a narrower gradient. The SAAG is essentially a bedside readout of whether the pathophysiology described above is at work.
Ascites Without Liver Disease
While cirrhosis causes roughly three-quarters of ascites cases, the remaining quarter comes from a mix of other conditions. Heart failure, especially right-sided failure, increases venous pressure throughout the body, including in the liver and splanchnic bed, producing ascites through a partly overlapping mechanism. Kidney failure leads to fluid overload from a different direction: impaired excretion of sodium and water independent of portal hypertension. Cancers, particularly ovarian and gastrointestinal malignancies, can cause malignant ascites through tumor deposits on the peritoneal lining that leak fluid and block lymphatic drainage. Tuberculosis, pancreatitis, and severe hypothyroidism are rarer culprits.
Each of these conditions has a somewhat different pathophysiological profile, which is why the SAAG and additional fluid tests matter. Heart failure ascites, for instance, typically produces a high SAAG because the mechanism still involves vascular congestion, while malignant and tuberculous ascites tend to produce a low SAAG because the mechanism involves peritoneal inflammation and direct fluid secretion. Recognizing which pathway is at work steers treatment in the right direction.
Spontaneous Bacterial Peritonitis
The presence of ascitic fluid creates a new vulnerability: infection. Spontaneous bacterial peritonitis, or SBP, occurs when gut bacteria cross the intestinal wall, enter the bloodstream, and colonize the ascitic fluid without any obvious source like a ruptured organ. In cirrhosis, this happens far more easily than it should because all three layers of defense against bacterial escape are weakened. The gut’s normal bacterial balance shifts toward more harmful species, the intestinal lining becomes more permeable, and the local immune system in the gut wall is impaired.11PubMed. Physiopathology of bacterial translocation and spontaneous bacterial peritonitis in cirrhosis
Once bacteria reach the ascitic fluid, the body’s ability to clear them is limited. The ascitic fluid itself has low levels of complement proteins and other immune factors, making it a poor environment for fighting infection. This failure of immune defense at multiple levels is why bacterial translocation is described as the key mechanism initiating SBP.12PubMed Central. Spontaneous bacterial peritonitis Clinically, SBP is a medical emergency that can rapidly worsen kidney function and trigger multi-organ failure if not treated promptly with antibiotics.
Hepatorenal Syndrome
At the far end of the ascites spectrum lies hepatorenal syndrome, a form of kidney failure that occurs in patients with advanced liver disease and ascites. The kidneys themselves are structurally normal. The problem is purely functional: the same arterial underfilling and hormonal activation that drive ascites eventually constrict the renal arteries so severely that the kidneys can no longer filter blood adequately.13PubMed Central. Hepatorenal Syndrome: Physiology, Diagnosis and Management Hepatorenal syndrome is essentially the final stage of the circulatory dysfunction that started with splanchnic vasodilation. Every compensatory mechanism has been pushed to its limit, and the kidneys bear the consequences. Without aggressive treatment or liver transplantation, the prognosis is poor.
How Treatments Target the Underlying Physiology
Knowing the mechanisms behind ascites explains why certain treatments work and what their risks are. Sodium restriction and diuretics are the first-line approach because the fundamental problem is renal sodium and water retention. Spironolactone, the most commonly used diuretic in ascites, directly blocks aldosterone, one of the key hormones driving sodium retention. Loop diuretics like furosemide are often added to increase sodium excretion further downstream in the kidney tubule.
When diuretics fail, large-volume paracentesis (draining liters of fluid from the abdomen with a needle) provides immediate relief. But removing that much fluid abruptly changes the pressure dynamics in the splanchnic bed. The mechanical decompression triggers further splanchnic vasodilation, worsening arterial underfilling and provoking a new surge of hormonal activation. This phenomenon, called paracentesis-induced circulatory dysfunction, can lead to rapid reaccumulation of ascites, worsening hyponatremia, kidney injury, and brain fog.14PubMed Central. Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review Infusing albumin during the procedure counters this by expanding the effective arterial volume and reducing the hormonal rebound. Without volume expansion, paracentesis-induced circulatory dysfunction becomes a serious concern, sometimes called a “silent killer” because it can cause harm without obvious immediate symptoms.15Egyptian Liver Journal. Paracentesis-induced circulatory dysfunction: are there albumin alternatives?
For patients with truly refractory ascites, a transjugular intrahepatic portosystemic shunt (TIPS) offers a more durable solution by attacking the problem at its root. TIPS is a stent placed inside the liver that creates a channel between the portal vein and a hepatic vein, allowing blood to bypass the scarred liver tissue. This directly reduces the portal pressure gradient. In studies, TIPS placement lowered the portal pressure gradient by roughly 46% at one month, with a corresponding increase in urinary sodium excretion and a decrease in renin, aldosterone, and norepinephrine levels.16Hepatology. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters In other words, lowering portal pressure improved effective blood volume enough that the hormonal systems driving sodium retention quieted down. TIPS also normalizes sinusoidal pressure, which helps explain why ascites resolves in many patients after placement.17PubMed Central. Transjugular intrahepatic portosystemic shunt in the management of refractory ascites
Angiogenesis and Splanchnic Vascular Remodeling
One area of research that has gained traction in the past two decades involves new blood vessel formation, or angiogenesis, in the splanchnic circulation. As portal hypertension develops, the gut’s vascular bed does not just passively dilate. It actively grows new vessels, driven in part by vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). In animal models, blocking both VEGF and PDGF reversed not only the new vessel growth but also the elevated portal pressure and the hyperdynamic splanchnic blood flow that characterize advanced liver disease.18PubMed. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
This finding matters because it suggests that the splanchnic vasodilation driving ascites is not just a functional dilation of existing vessels but involves a structural remodeling of the vascular network. Targeting those growth signals could theoretically interrupt the cascade much earlier than current treatments do. The research is still in animal models, and translating anti-angiogenic strategies to patients with cirrhosis comes with serious safety concerns, since these drugs can impair wound healing and cause bleeding. Still, the work has shifted how researchers think about portal hypertension: it is not a static plumbing problem but a dynamic, biologically active process that the body continues to reshape over time.
Ascites and the Peritoneal Lining
The peritoneum, the thin membrane that lines the abdominal cavity and covers the organs, is often treated as a passive container in discussions of ascites. But it is a living tissue that responds to the fluid pressing against it. Research on malignant ascites has shown that the physical compression from accumulated fluid alters the surface of peritoneal mesothelial cells, causing them to retract, change shape, and form tiny intercellular projections called tunneling nanotubes.19Nature / Scientific Reports. Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer In the context of cancer, these changes make the peritoneum more hospitable to metastatic cells trying to implant. While this specific mechanism is most relevant to malignant ascites rather than cirrhotic ascites, it underscores that fluid accumulation is not a benign mechanical event. The peritoneum remodels in response to pressure, and those changes can have consequences beyond simple discomfort.